Follow the Aspira Pathlab stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €941.8m. The latest transaction was disclosed on 28 August 2026 (Acquisition). Among the most active insiders: Jay Arvind Bhanushali. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€258
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Buys €258n/a Sells
Fundamental score
Ranked 20,497 of 29,062 companies
38.0
score / 100
Value
26
Quality
50
FCF yld0.8%
Earn yld0.1%
EV/EBITDA48.5x
ROE0.4%
Gross mgn77%
Net mgn0.2%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Aspira Pathlab es una empresa especializada en servicios de diagnóstico médico, que ofrece análisis de laboratorio y pruebas de salud. Opera en el mercado XBOM.